Authors
Loading...
Evaluation shows significant cytotoxic activity of heterocycles against breast and colon cancer, suggesting potential as CDK2 inhibitors.
El‐Helw et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: